Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor-specific
100%
CD8+ T Cells
100%
Therapeutic Efficacy
100%
PI3K Inhibitor
100%
Phosphoinositide 3-kinase (PI3K)
66%
PI3K Isoforms
50%
Proliferative Activity
33%
Tumor
16%
Cell Differentiation
16%
Terminal Differentiation
16%
Antigen-specific CD8+ T Cells
16%
CD8+ T
16%
Effector Cells
16%
Adoptive Transfer
16%
Therapeutic Action
16%
Isoform-selective Inhibitor
16%
Proliferative Potential
16%
Adoptive Cell Therapy
16%
Tumor Immunity
16%
Memory Phenotype
16%
Granzyme B
16%
Cell-based Vaccine
16%
Adoptive Cell Transfer
16%
Peptide Vaccine
16%
Tumor-specific Peptides
16%
Akt Isoforms
16%
Antitumor Therapeutics
16%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
CD8
100%
Isoform
50%
Cytokine
12%
Cellular Differentiation
12%
Tumor Antigen
12%
Granzyme B
12%
Vaccine Peptide
12%
Protein Kinase B
12%
Immunology and Microbiology
Cytotoxic T-Cell
100%
Immunotherapy
12%
Cytokine
12%
Cell Differentiation
12%
Tumor Antigen
12%
Effector Cell
12%
Transfer Cell
12%
Granzyme B
12%
Peptide Vaccine
12%